Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

276.37
-1.5300-0.55%
Volume:42.88K
Turnover:11.92M
Market Cap:148.59B
PE:36.56
High:278.99
Open:278.47
Low:276.30
Close:277.90
Loading ...

US Equity Indexes Mixed in Midday Trading

MT Newswires Live
·
25 Feb

Nike, Travelers Share Gains Contribute To Dow's Nearly 125-Point Climb

Dow Jones
·
25 Feb

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-02-24

Reuters
·
25 Feb

Is Amgen Inc. (AMGN) One of the Best Performing Dow Stocks So Far in 2025?

Insider Monkey
·
24 Feb

5 Stocks in the Dow ETF That Survived the Worst Week Since October

Zacks
·
24 Feb

Market Chatter: Amgen to Invest $200 Million in India Site in 2025

MT Newswires Live
·
24 Feb

Amgen (NASDAQ:AMGN) to Invest $200M in India High Tech Site as Trump Tariffs Loom

TIPRANKS
·
24 Feb

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

Zacks
·
24 Feb

Drugmaker Amgen to invest $200 million in India site, CEO says

Reuters
·
24 Feb

Amgen plans $200 million investment in India site, CEO says

Reuters
·
24 Feb

Amgen CEO Bradway - Will Initially Invest $200 Mln in 2025 in Technology Centre in Hyderabad, India

THOMSON REUTERS
·
24 Feb

Amgen National Executive India - North of 2000 People Will Be Joining by End of Year in Amgen India’s Technology and Innovation Centre

THOMSON REUTERS
·
24 Feb

Amgen National Executive India- 300 People Are Already Working, 300 Will Be Joining in Amgen India’s Technology and Innovation Centre

THOMSON REUTERS
·
24 Feb

Amgen Inc. (AMGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Insider Monkey
·
23 Feb

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Feb

BUZZ-Alvotech rallies after US biosimilar launch

Reuters
·
22 Feb

4 Seniors & Aging Demographics Stocks to Watch Right Now

Zacks
·
22 Feb

Teva Pharma and Alvotech launch biosimilar to J&J's Stelara in US

Reuters
·
21 Feb

Indian drugmakers can retain US dominance even with tariffs, says industry body

Reuters
·
21 Feb

There May Be Some Bright Spots In Amgen's (NASDAQ:AMGN) Earnings

Simply Wall St.
·
21 Feb